Eli Lilly to offer early access to next-gen obesity drug to some patients
- Posted on August 3, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Eli Lilly to offer early access to next-gen obesity drug to some patients
By Sneha S K and Deena Beasley Aug 3 (Reuters) - Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval. "For a limited number of patients who meet specific medical criteria and cannot enroll in a clinical trial, we believe it is medically appropriate to make authentic retatrutide
